Work

A Phase 2 trial of AI-BEL (AZT/Interferon-α plus Belinostat) for HTLV-1 related adult T-cell leukemia-lymphoma: Final safety and efficacy Results

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-563

Authors: Georgios Pongas, Isildinha Reis, Ngoc Toomey, Catalina Amador, Yi Zhou, Erik Guillen, Gregoire Lauvau, B. Hilda Ye, Jennifer Chapman, Juan Carlos Ramos

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Albert Einstein College of Medicine

Language: English

Topic: T-cell and Retrovirus Studies

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417010295

Cites:

Cited by:

Related to: